Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-16-000076
Filing Date
2016-05-06
Accepted
2016-05-06 08:43:01
Documents
84
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20160331x10q.htm 10-Q 1438470
2 EX-31.1 petx-20160331xex31_1.htm EX-31.1 19955
3 EX-31.2 petx-20160331xex31_2.htm EX-31.2 20235
4 EX-32.1 petx-20160331xex32_1.htm EX-32.1 6791
5 EX-32.2 petx-20160331xex32_2.htm EX-32.2 7381
6 GRAPHIC petx-20160331x10qg001.jpg GRAPHIC 44874
7 GRAPHIC petx-20160331x10qg002.jpg GRAPHIC 50883
8 GRAPHIC petx-20160331x10qg003.jpg GRAPHIC 26428
  Complete submission text file 0001509190-16-000076.txt   6992861

Data Files

Seq Description Document Type Size
9 EX-101.INS petx-20160331.xml EX-101.INS 1680311
10 EX-101.SCH petx-20160331.xsd EX-101.SCH 48725
11 EX-101.CAL petx-20160331_cal.xml EX-101.CAL 53740
12 EX-101.DEF petx-20160331_def.xml EX-101.DEF 172370
13 EX-101.LAB petx-20160331_lab.xml EX-101.LAB 354692
14 EX-101.PRE petx-20160331_pre.xml EX-101.PRE 333220
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

EIN.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 161626015
SIC: 2834 Pharmaceutical Preparations